PlexusDx Precision Peptide Genetic Test examines 14 metabolic and cardiovascular pathwaysincluding GLP1R and GIPR variantsto forecast how your body will likely process tirzepatide and adjust your treatment plan accordingly
Laboratory studies have demonstrated potential neuroprotective effects, including reducing oxidative stress, decreasing inflammation, promoting neuronal survival, and enhancing mitochondrial functionall processes that are impaired in Parkinson's disease
Eden advertises compounded semaglutide from $99/month but that headline is medication only, and Eden requires a separate membership
Obesity medicine specialists, endocrinologists, and increasingly primary care physicians manage these medications
Individuals at risk of AD or with diabetes may be in the early or middle biological stage of AD, offering a greater opportunity for GLP-1RAs to provide neuroprotection